Cognitive and neurological impairment in mood disorders

Psychiatric Clinics of North America

Volumn 27, Issue 1, 2004, Pages 19-36

  Marvel, Cherie L ^a   Paradiso, Sergio ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ATTENTION; BIPOLAR DEPRESSION; BODY MOVEMENT; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN FUNCTION; CATATONIA; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFECT; HUMAN; MAJOR DEPRESSION; MANIA; MEDICAL INFORMATION; MENTAL PATIENT; MOOD DISORDER; MOTOR PERFORMANCE; MYOCLONUS; NEUROANATOMY; NEUROIMAGING; NEUROLOGIC DISEASE; PARKINSONISM; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOMOTOR RETARDATION; PSYCHOPHARMACOLOGY; RESTLESSNESS; REVIEW; TARDIVE DYSKINESIA; TREATMENT OUTCOME; WORKING MEMORY;

ATTENTION; BRAIN; CATATONIA; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MEMORY DISORDERS; MOOD DISORDERS; MYOCLONUS; PARKINSONIAN DISORDERS; PSYCHOMOTOR AGITATION;

EID: 1642383474     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00106-0     Document Type: Review

References (88)

1. Andreasen N., Black D. Introductory textbook of psychiatry. 1995;American Psychiatric Press, Washington (DC).
2. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th edition (DSM-IV):1994;American Psychiatric Association, Washington (DC).
3. Rabins P.V., Merchant A. Criteria for diagnosing reversible dementia caused by depression: validation by 2-year follow-up. Br J Psychiatry. 144:1984;488-492.
4. Wilson R.S., Barnes L.L., Mendes de Leon C.F., et al. Depressive symptoms, cognitive decline and risk of AD in older persons. Neurology. 59:(3):2002;364-370.
5. Rosvold H.E., Mirsky A.F., Sarason I., et al. A continuous performance test of brain damage. J Consult Psychol. 20:1956;343-350.
6. Zubieta J.K., Huguelet P., O'Neil R.L., et al. Cognitive function in euthymic bipolar I disorder. Psychiatry Res. 102:(1):2001;9-20.
7. Sax K.W., Strakowski S.M., McElroy S.L., et al. Attention and formal thought disorder in mixed and pure mania. Biol Psychiatry. 37:(6):1995;420-423.
8. Brand N., Jolles J. Information processing in depression and anxiety. Psychol Med. 17:(1):1987;145-153.
9. Reitan R.M., Wolfson D. The Halstead-Reitan neuropsychological test battery. 1985;Neuropsychology Press, Tuscon (AZ).
10. Weschler D. Wechsler Adult Intelligence Scale-Revised (WAIS-R) manual. 1981;The Psychological Corporation, New York.
11. Ilsley J.E., Moffoot A.P. An analysis of memory dysfunction in major depression. J Affect Disord. 35:(1-2):1995;1-9.
12. Paradiso S., Lamberty G.J., Garvey M.J., et al. Cognitive Impairment in the Euthymic Phase of Chronic Unipolar Depression. J Nerv Ment Dis. 185:(12):1997;748-754.
13. Austin M.P., Ross M., Murray C., et al. Cognitive function in major depression. J Affect Disord. 25:(1):1992;21-29.
14. McGrath J., Scheldt S., Welham J., et al. Performance on tests sensitive to impaired executive ability in schizophrenia, mania, and well controls: acute and subacute phases. Schizophr Res. 26:1997;127-137.
15. Gourovitch M.L., Torrey E.F., Gold J.M., et al. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry. 45:(5):1999;639-646.
16. Heaton R.K. Wisconsin Card Sorting Test Manual. 1981;Psychological Assessment Resources, Odessa (FL).
17. Golden C.J. Stroop color and word test: a manual for clinical and experimental uses. 1978;Stoelting, Wood Dale (IL).
18. van Gorp W.G., Altshuler L., Theberge D.C., et al. Declarative and procedural memory in bipolar disorder. Biol Psychiatry. 46:(4):1999;525-531.
19. Calev A., Korin Y., Shapira B., et al. Verbal and nonverbal recall by depressed and euthymic affective patients. Psychol Med. 16:(4):1986;789-794.
20. Nissen M.J., Willingham D., Hartman M. Explicit and implicit remembering: when is learning preserved in amnesia? Neuropsychologia. 27:(3):1989;341-352.
21. Gras-Vincendon A., Danion J.M., Grange D., et al. Explicit memory, repetition priming and cognitive skill learning in schizophrenia. Schizophr Res. 13:1994;117-126.
22. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 11:(2):2001;240-249.
23. Damasio A.R. The feeling of what happens: body and emotion in the making of consciousness. 1999;Harcourt Brace, New York.
24. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:(22):1998;13290-13295.
25. Drevets W.C., Price J.L., Simpson J.R., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
26. Drevets W.C., Ongur D., Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry. 3:1998;190-226.
27. Hirayasu Y., Shenton M.E., Salisbury D.F., et al. Subgenual cingulated cortex volume in first-episode psychosis. Am J Psychiatry. 156:1999;1091-1093.
28. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci. 985:2003;420-444.
29. Davidson R.J., Lewis D.A., Alloy L.B., et al. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry. 52:(6):2002;478-502.
30. Beyer J.L., Krishnan K.R. Volumetric brain imaging findings in mood disorders. Bipolar Disord. 4:(2):2002;89-104.
31. Coffey C.E., Wilkinson W.E., Weiner R.D., et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry. 50:1993;7-16.
32. Goodwin G.M. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J Psychopharmacol. 11:1997;115-122.
33. Bench C.J., Friston K.J., Brown R.G., et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med. 23:1993;579-590.
34. Buchsbaum M.S., Wu J., Siegel B.V., et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 41:1997;15-22.
35. Goodwin G.M., Austin M.P., Dougall N., et al. State changes in brain activity shown by the uptake of 99′Tc-exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disord. 29:1993;243-253.
36. Baxter L.R., Schwartz J.M., Phelps M.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
37. Martinot J.L., Hardy P., Feline A., et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry. 147:1990;1313-1317.
38. Bremner J.D., Narayan M., Anderson E.R., et al. Hippocampal volume reduction in major depression. Am J Psychiatry. 157:2000;115-118.
39. Shah P.J., Ebmeier K.P., Glabus M.F., et al. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry. 172:1998;527-532.
40. Sheline Y.I., Wang P.W., Gado M.H., et al. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 93:1996;3908-3913.
41. Sheline Y.I., Sanghavi M., Mintun M.A., et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 19:1999;5034-5043.
42. Altshuler L.L., Bartzokis G., Grieder T., et al. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry. 55:1998;663-664.
43. Brambilla P., Harenski K., Nicoletti M., et al. MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res. 37:2003;287-295.
44. Strakowski S.M., DelBello M.P., Sax K.W., et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry. 56:1999;254-260.
45. Husain M.M., McDonald W.M., Doraiswamy P.M., et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res. 40:1991;95-99.
46. Krishnan K.R., McDonald W.M., Escalona P.R., et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry. 49:1992;553-557.
47. Strakowski S.M., Adler C.M., DelBello M.P. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord. 4:(2):2002;80-88.
48. Borkowska A., Rybakowski J.K. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord. 3:(2):2001;88-94.
49. Dolan R.J., Bench C.J., Brown R.G., et al. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry. 55:(9):1992;768-773.
50. Bench C.J., Friston K.J., Brown R.G., et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med. 23:(3):1993;579-590.
51. Dolan R.J., Bench C.J., Brown R.G., et al. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow. Psychol Med. 24:(4):1994;849-857.
52. 15 PET). Neuropsychiatry Neuropsychol Behav Neurol. 7:1994;143-153.
53. Elliott R., Baker S.C., Rogers R.D., et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med. 27:(4):1997;931-942.
54. de Asis J.M., Stern E., Alexopoulos G.S., et al. Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. Am J Psychiatry. 158:(8):2001;1321-1323.
55. George M.S., Ketter T.A., Parekh P.I., et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci. 9:(1):1997;55-63.
56. Blumberg H.P., Stern E., Ricketts S., et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry. 156:(12):1999;1986-1988.
57. Rubinsztein J.S., Fletcher P.C., Rogers R.D., et al. Decision-making in mania: a PET study. Brain. 124:2001;2550-2563.
58. Blumberg H.P., Leung H.C., Skudlarski P., et al. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry. 60:(6):2003;601-609.
59. Sabbe B., Hulstijn W., Van Hoof J., et al. Fine motor retardation and depression. J Psychiatr Res. 30:(4):1996;295-306.
60. Caligiuri M.P., Ellwanger J. Motor and cognitive aspects of motor retardation in depression. J Affect Disord. 57:2000;83-93.
61. Moffoot A.P., O'Carroll R.E., Bennie J., et al. Diurnal variation of mood and neuropsychological function in major depression with melancholia. J Affect Disord. 32:(4):1994;257-269.
62. Perugi G., Akiskal H.S., Micheli C., et al. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord. 67:2001;105-114.
63. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;53-62.
64. Goel N., Terman M. Depressive symptomatology differentiates subgroups of patients with seasonal mood disorder. Depress Anxiety. 15:(1):2002;34-41.
65. Starkstein S.E., Petracca G., Teson A., et al. Catatonia in depression: prevalence, clinical correlates and validation of a scale. J Neurol Neurosurg Psychiatry. 60:(3):1996;326-332.
66. Joseph A.B. Catatonia. Joseph A.B., Young R.R. Movement disorders in neurology and neuropsychiatry. 2nd edition:1999;311-317 Blackwell Science, Malden (MA).
67. Lemus C.Z., Lieberman J.A. Antidepressant-induced myoclonus. Joseph A.B., Young R.R. Movement disorders in neurology and neuropsychiatry. 2nd edition:1999;129-134 Blackwell Science, Malden (MA).
68. Sternbach H. The Serotonin Syndrome. Am J Psychiatry. 148:(6):1991;705-713.
69. Garvey M.J., Tollefson G.D. Occurrence of Myoclonus in patients treated with cyclic antidepressants. Arch Gen Psychiatry. 44:(3):1987;269-272.
70. Stahl S.M. Essential psychopharmacology: Neuroscientific basis and practical applications. 2000;Cambridge University Press, Cambridge (UK).
71. Caviness J.N., Evidente V.G. Cortical myoclonus during lithium exposure. Arch Neurol. 60:(3):2003;401-404.
72. Casey D.E. Mood-dependent tardive dyskinesia. Joseph A.B., Young R.R. Movement disorders in neurology and neuropsychiatry. 2nd edition:1999;376-379 Blackwell Science, Malden (MA).
73. Kane J.M., Woener M., Weinhold P., et al. Incidence and severity of tardive dyskinesia in affective illness. Gardos G., Casey D.E. Tardive dyskinesia and affective disorders. 1984;21-28 American Psychiatric Association, Washington, DC.
74. de Potter R.W., Linkowski P. State-dependent tardive dyskinesia in manic-depressive illness. J Neurol Neurosurg Psychiatry. 46:(7):1983;666-668.
75. Yazici O., Kantemir E., Tastaban Y., et al. spontaneous improvement of tardive dystonia during mania. Br J Psychiatry. 158:1991;847-850.
76. Himmelhoch J.M. Bipolar disorder and dyskinesias. Joseph A.B., Young R.R. Movement disorders in neurology and neuropsychiatry. 2nd edition:1999;345-351 Blackwell Science, Malden (MA).
77. Starkstein S.E., Petracca G., Chemerinski E., et al. Prevalence and correlates of parkinsonism in patients with primary depression. Neurology. 57:(3):2001;553-555.
78. Fahn S., Elton E., UPDRS Program Members. Unified Parkinson's Disease rating scale. Fahn S., Marsden C.D., Golstein M., et al. Recent developments in Parkinson's Disease. vol. 2:1987;153-163 Macmillan: Healthcare Information, Florham Park (NJ).
79. Levy M.L., Cummings J.L. Parkinson's disease and parkinsonism. Joseph A.B., Young R.R. Movement disorders in neurology and neuropsychiatry. 2nd edition:1999;171-179 Blackwell Science, Malden (MA).
80. Gilleard C.J., Vaddadi K.S. Mood, memory and motor performance and the severity of tardive dyskinesia. Percept Mot Skills. 63:(3):1986;1037-1038.
81. Waddington J.L., Youssef H.A. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness and exposure to neuroleptics and lithium. Am J Psychiatry. 145:(5):1988;613-616.
82. Wade J.B., Taylor M.A., Kasprisin A., et al. Tardive dyskinesia and cognitive impairment. Biol Psychiatry. 22:(3):1987;393-395.
83. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 49:2001;741-752.
84. Benes F.M., Kwok E.W., Vincent S.L., et al. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic-depressives. Biol Psychiatry. 44:1998;88-97.
85. Sax K.W., Strakowski S.M., Zimmerman M.E., et al. Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry. 156:(1):1999;139-141.
86. Buchsbaum M.S., Wu J., DeLisi L.E., et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord. 9:1986;137-152.
87. Ketter T.A., Kimbrell T.A., George M.S., et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry. 49:2001;97-109.
88. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J Psychiatr Res. 31:1997;393-432.